Residual Risk of Cardiovascular Complications in Case of Adequate Lipid-Lowering Therapy

VV V Simerzin, OV V Fatenkov, IV V Gagloeva, MA A Galkina, YaA A Panisheva
2018 Nauka i innovacii v medicine  
This article is devoted to the problems of residual risk of cardiovascu1ar comp1ications deve1opment for high and very high risk patients under adequate lipid-fowering pharmacotherapy in spite of c^lestera! and tow-density 1ipoproteins target level achievement. Afong with classic risk factors the special atte^ton is given to 1ipoprotein (a) [LP (a)] as the most aggressive factor of cardwvascular system atherosclerotic diseases devetopment and their comp1ications. Great importance is attached to
more » ... ance is attached to 1ipidopheresis.
doi:10.35693/2500-1388-2018-0-2-19-25 fatcat:yju7s5wbsfap3fweycfjzgkypy